Search hospitals > Washington > Tacoma
MultiCare Institute for Research and Innovation
Claim this profileTacoma, Washington 98405
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Thyroid Cancer
Conducts research for Postprandial Fullness Syndrome
Conducts research for Prostate Cancer
112 reported clinical trials
8 medical researchers
Summary
MultiCare Institute for Research and Innovation is a medical facility located in Tacoma, Washington. This center is recognized for care of Breast Cancer, Lung Cancer, Thyroid Cancer, Postprandial Fullness Syndrome, Prostate Cancer and other specialties. MultiCare Institute for Research and Innovation is involved with conducting 112 clinical trials across 308 conditions. There are 8 research doctors associated with this hospital, such as Jennifer Slim, John A. Keech, Anuradha Belur, MD, and Bhuvana Sunil.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
Stage III
2Lung Cancer
Global LeaderStage I
Stage II
Stage IV
Top PIs
Jennifer SlimMultiCare Gig Harbor Medical Park7 years of reported clinical research
Studies Thyroid Cancer
Studies Breast Cancer
18 reported clinical trials
50 drugs studied
John A. KeechMultiCare Auburn Medical Center9 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
3 reported clinical trials
12 drugs studied
Anuradha Belur, MDMultiCare Institute for Research and Innovation3 years of reported clinical research
Studies Diarrhea
Studies Solid Tumors
2 reported clinical trials
3 drugs studied
Bhuvana SunilMultiCare Institute for Research & Innovation3 years of reported clinical research
Studies Type 1 Diabetes
Studies Precocious Puberty
2 reported clinical trials
2 drugs studied
Clinical Trials running at MultiCare Institute for Research and Innovation
Ovarian Cancer
Non-Small Cell Lung Cancer
Angelman Syndrome
Non-Hodgkin's Lymphoma
Hypothyroidism
Lung Cancer
Hypogonadotropic Hypogonadism
Bilateral Testicular Torsion
Testicular Hypogonadism
Postprandial Fullness Syndrome
CBX-12
for Ovarian Cancer
The purpose of this study is to assess the safety, tolerability, and efficacy of CBX-12 in female subjects with platinum resistant or refractory ovarian cancer at 2 doses; 125 mg/m2 every 21 days or 100 mg/m2 every 21 days.
Recruiting1 award Phase 23 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at MultiCare Institute for Research and Innovation?
MultiCare Institute for Research and Innovation is a medical facility located in Tacoma, Washington. This center is recognized for care of Breast Cancer, Lung Cancer, Thyroid Cancer, Postprandial Fullness Syndrome, Prostate Cancer and other specialties. MultiCare Institute for Research and Innovation is involved with conducting 112 clinical trials across 308 conditions. There are 8 research doctors associated with this hospital, such as Jennifer Slim, John A. Keech, Anuradha Belur, MD, and Bhuvana Sunil.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.